Results 221 to 230 of about 78,533 (262)
Some of the next articles are maybe not open access.
Biomarkers and ST-elevation myocardial infarction
Heart, 2013In the recent Heart paper, Cuculi et al 1 from Oxford University challenge two conventional wisdoms in clinical cardiology: first, biomarkers do not have a role in the management of patients presenting with suspected ST-elevation myocardial infarction (STEMI); and second, in the absence of cardiogenic shock, there is no remaining unmet clinical need in
openaire +2 more sources
Synthetic cannabinoids and ST elevation myocardial infarction
The American Journal of the Medical Sciences, 2022Synthetic cannabinoids cannot be detected on a standard urine drug screen (UDS), making them a convenient drug of abuse. We report the first case of ST elevation myocardial infarction (STEMI) in a young patient due to coronary artery thrombosis secondary to synthetic cannabinoid use and concurrent COVID-19 infection.
Ali Haider, Jafry +6 more
openaire +2 more sources
Transradial Intervention in ST Elevation Myocardial Infarction
Current Cardiology Reports, 2015Primary percutaneous coronary intervention (PPCI) in ST elevation myocardial infarction (STEMI) represents the current gold standard reperfusion therapy. Recent advances in antiplatelet and anticoagulant therapy have reduced the risk of ischemic complications and mortality in PPCI although this has been at the expense of major bleeding complications ...
Mustafa, Ahmad H S +6 more
openaire +2 more sources
Journal of Electrocardiology, 2011
It is well accepted that early reperfusion is beneficial in patients with acute myocardial infarction presenting with ST elevation (STE). Earlier studies suggested lack of beneficial effects in patients presenting without STE and even with ST depression.
Henry D, Huang, Yochai, Birnbaum
openaire +2 more sources
It is well accepted that early reperfusion is beneficial in patients with acute myocardial infarction presenting with ST elevation (STE). Earlier studies suggested lack of beneficial effects in patients presenting without STE and even with ST depression.
Henry D, Huang, Yochai, Birnbaum
openaire +2 more sources
ACUTE ST-ELEVATION MYOCARDIAL INFARCTION
Acta Clinica Belgica, 2006Acute ST-elevation myocardial infarction (STEMI) remains the leading cause of death in industrialized countries. For many patients, a myocardial infarction is the first presentation of atherosclerotic coronary artery disease. This often results in delays in obtaining medical attention and subsequently poorer outcome, certainly because symptoms are ...
openaire +2 more sources
A LEOPARD Mimicking ST-Elevation Myocardial Infarction
The American Journal of Cardiology, 2011A 47-year-old man was referred because of an acute anterolateral ST-segment elevation myocardial infarction. Coronary angiography showed marked ectasia of the coronary arteries, with no obstructive lesions. Ventriculography strongly suggested severe left ventricular hypertrophy, later confirmed by cardiovascular magnetic resonance imaging.
Rodrigo, Bagur +4 more
openaire +2 more sources
Gender and ST-elevation myocardial infarction
Revista Española de Cardiología (English Edition), 2021Antonia, Sambola +3 more
openaire +2 more sources
ST-Elevation Myocardial Infarction
American Journal of Critical Care, 2002Mary G, Adams, Michele M, Pelter
openaire +2 more sources
ST-Elevation Myocardial Infarction and Non-ST-Elevation Myocardial Infarction
Critical Care Nursing Clinics of North America, 2019Deedra H. Harrington +2 more
openaire +1 more source
ST-Elevation Myocardial Infarction Track
Therapeutic Hypothermia and Temperature Management, 2021Benjamin S, Abella +3 more
openaire +2 more sources